Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6544
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis ; day:22 ; month:4 ; year:2016 ; pages:1-16
Cardiology and therapy ; (22.4.2016), 1-16
- Urheber
-
Vallakati, Ajay
- Beteiligte Personen und Organisationen
-
Sharma, Abhishek
Madmani, Mohammed
Reddy, Madhu
Kanmanthareddy, Arun
Gunda, Sampath
Lakkireddy, Dhanunjaya
Lewis, William R.
SpringerLink (Online service)
- DOI
-
10.1007/s40119-016-0061-7
- URN
-
urn:nbn:de:1111-2016042332006
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vallakati, Ajay
- Sharma, Abhishek
- Madmani, Mohammed
- Reddy, Madhu
- Kanmanthareddy, Arun
- Gunda, Sampath
- Lakkireddy, Dhanunjaya
- Lewis, William R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
Incidental ablation of ganglionated plexus during atrial fibrillation ablation
Atrial fibrillation ablation in heart failure patients
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Hybrid ablation for atrial fibrillation: a systematic review
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
Incidental ablation of ganglionated plexus during atrial fibrillation ablation
Atrial fibrillation ablation in heart failure patients
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Hybrid ablation for atrial fibrillation: a systematic review
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
New Anticoagulants for Atrial Fibrillation
New Anticoagulants for Atrial Fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
Incidental ablation of ganglionated plexus during atrial fibrillation ablation
Atrial fibrillation ablation in heart failure patients
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Hybrid ablation for atrial fibrillation: a systematic review
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks